In lung adenocarcinoma, a study reported that KIAA1429 was amplified in 7.3% of patients, which is significantly higher than METTL3, METTL14, and WTAP, suggesting that KIAA1429 may be the major driver of oncogenesis among these components of the methyltransferase complex [23]. Here, VIRMA is linked to lung adenocarcinoma.